Welcome to LookChem.com Sign In|Join Free
  • or
3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-7-hydroxy-4H-chromen-4-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

96754-91-5

Post Buying Request

96754-91-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96754-91-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 96754-91-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,7,5 and 4 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 96754-91:
(7*9)+(6*6)+(5*7)+(4*5)+(3*4)+(2*9)+(1*1)=185
185 % 10 = 5
So 96754-91-5 is a valid CAS Registry Number.

96754-91-5Relevant academic research and scientific papers

7-Hydroxy-benzopyran-4-one derivatives: A novel pharmacophore of peroxisome proliferator-activated receptor α and -γ (PPARα and γ) dual agonists

Matin, Azadeh,Gavande, Navnath,Kim, Moon S.,Yang, Nancy X.,Salam, Noeris K.,Hanrahan, Jane R.,Roubin, Rebecca H.,Hibbs, David E.

experimental part, p. 6835 - 6850 (2010/04/04)

Design, synthesis, and in vitro bioevaluation of a new class of potential dual PPARα and γ agonists discovered through a structure-driven design paradigm are described. The 7-hydroxy-benzopyran-4-one moiety (includes flavones, flavanones, and isoflavones) is the key pharmacophore of these novel molecules, exhibiting similarity to the core structure of both fibrates and thiazolidinediones. New lead PPAR ligands were identified from "natraceuticals" and synthetic analogues. In total, 77 molecules, including chalcones, flavones, flavanones, isoflavones, and pyrazole derivatives, were screened and structure-activity relationship studies of the dual agonists undertaken. Compounds 68, 70, 72, and 76 were identified as novel and potent dual PPARα and γ agonists. These novel molecules may have the potential to be the future leads in PPAR-related disorders, including type II diabetes mellitus and metabolic syndrome. 2009 American Chemical Society.

FLAVONOID PPAR AGONISTS

-

Page/Page column 36; 67, (2009/04/25)

The present invention relates to PPAR agonists, and their use in therapy including the treatment of disease. In particular, the invention relates to flavonoid compounds which are PPAR-gamma agonists and/or PPAR alpha/gamma dual agonists.

SYNTHETIC AND MODIFIED ISOFLAVONOIDS. III. SYNTHESIS OF BENZODIOXANE ANALOGUES OF PSEUDOBAPTIGENIN

Aitmambetov, A.,Grishko, L. G.,Khilya, V. P.

, p. 720 - 725 (2007/10/02)

Benzodioxane analogues of pseudobaptigenin with alkyl fragments in positions 2 and 6 of the chromone ring have been synthesized from α-(1,4-benzodioxan-6-yl)-2-hydroxy-6-alkylacetophenones.

Mixed Anhydride of Acetic and Formic Acids in the Synthesis of Chromones. 2. Synthesis of 3-Arylchromones

Pivovarenko, V. G.,Khilya, V. P.

, p. 497 - 502 (2007/10/02)

A study was carried out on the reaction of α-substituted 2-hydroxyacetophenones eith the mixed anhydride of acetic and formic acids in the presence of bases of different strength.Chromones containing a conjugated electron-withdrawing substituent at C(3) are formed in close to quantitative yield in the presence of triethylamine.The preparation of chromones containing an unconjugated substituent under these conditions is recommended only for 5-hydroxychromones.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 96754-91-5